Patients Diagnosed With Scleroderma: Physical Performance and Functionality
Investigating the Relationship Between the Biopsychosocial Status of Individuals Diagnosed With Scleroderma and Their Physical Performance and Functionality
Hacettepe University
50 participants
Aug 4, 2025
OBSERVATIONAL
Conditions
Summary
Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. In light of all this literature, the aim was to evaluate the biopsychosocial characteristics of both pediatric and adult scleroderma patients and to examine their physical performance and functionality. Additionally, this study aims to identify effective tests that can be used in future research to assess physical performance and functionality in individuals diagnosed with scleroderma.
Eligibility
Inclusion Criteria5
- *For a child diagnosed with scleroderma*
- Cases diagnosed with scleroderma,
- Cases aged 7-18 years will be included.
- Individuals diagnosed with scleroderma,
- Individuals over the age of 18 will be included.
Exclusion Criteria9
- Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
- Cases that are not willing to participate in the study will be excluded.
- Having participated in a regular exercise program for the past 3 months
- Individuals who are not willing to participate in the study
- *For adults diagnosed with scleroderma*
- Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
- Individuals who are not willing to participate in the study will be excluded.
- Having participated in a regular exercise program for the past 3 months
- Individuals who are not willing to participate in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Scales and functionality tests will be applied to cases diagnosed with scleroderma
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07183072